María D Ballesteros-Pomar1, Tomás González de Francisco2, Ana Urioste-Fondo3, Luis González-Herraez4, Alicia Calleja-Fernández5, Alfonso Vidal-Casariego6, Vicente Simó-Fernández7, Isidoro Cano-Rodríguez8. 1. High Risk Obesity Unit, Department of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, Altos de Nava s/n, Edificio Administrativo Ala Sur, 2ª planta, 24008, León, Spain. mdballesteros@telefonica.net. 2. High Risk Obesity Unit, Department of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, Altos de Nava s/n, Edificio Administrativo Ala Sur, 2ª planta, 24008, León, Spain. gonzalezdefrancisco@gmail.com. 3. High Risk Obesity Unit, Department of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, Altos de Nava s/n, Edificio Administrativo Ala Sur, 2ª planta, 24008, León, Spain. anaurifon@gmail.com. 4. High Risk Obesity Unit, Department of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, Altos de Nava s/n, Edificio Administrativo Ala Sur, 2ª planta, 24008, León, Spain. luisghg19@gmail.com. 5. High Risk Obesity Unit, Department of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, Altos de Nava s/n, Edificio Administrativo Ala Sur, 2ª planta, 24008, León, Spain. calleja.alicia@gmail.com. 6. High Risk Obesity Unit, Department of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, Altos de Nava s/n, Edificio Administrativo Ala Sur, 2ª planta, 24008, León, Spain. avcyo@hotmail.com. 7. High Risk Obesity Unit, Department of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, Altos de Nava s/n, Edificio Administrativo Ala Sur, 2ª planta, 24008, León, Spain. vicsim77@gmail.com. 8. High Risk Obesity Unit, Department of Endocrinology and Nutrition, Complejo Asistencial Universitario de León, Altos de Nava s/n, Edificio Administrativo Ala Sur, 2ª planta, 24008, León, Spain. isicano@picos.com.
Abstract
BACKGROUND: Bariatric surgery is currently the treatment of choice for those patients with severe obesity, but the procedure of choice is not clearly established. We describe weight loss and nutritional parameters in severely obese patients after biliopancreatic diversion for 10 years of follow-up. METHODS: Patients were followed by the same multidisciplinary team, and data are shown for 10 years. Bariatric Analysis and Reporting Outcome System (BAROS) questionnaire, data regarding the evolution of obesity-related diseases, and nutritional parameters are reported. RESULTS: Two hundred ninety-nine patients underwent biliopancreatic diversion, 76.1 % women, initial BMI 50.1 kg/m(2) (7.2). Weight loss was maintained throughout 10 years with EWL% around 65 % and EBMIL% around 70 %. More than 80 % of the patients showed EWL higher than 50 %. Blood pressure, glucose metabolism, and lipid profile clearly improved after surgery. Mean nutritional parameters remained within the normal range during follow-up. Protein malnutrition affected less than 4 % and anemia up to 16 %. Fat-soluble vitamin levels decreased along the time, with vitamin D deficiency in 61.5 % of patients. No significant differences were found either in nutritional parameters or weight loss regarding gastrectomy or gastric preservation, or common limb length longer or shorter than 55 cm CONCLUSIONS: Biliopancreatic diversion is an effective surgical procedure in terms of weight loss, quality of life, and evolution of obesity-related diseases. Nutritional deficiencies are less frequent than feared for a malabsorptive procedure, but must be taken into account, especially for fat-soluble vitamins.
BACKGROUND: Bariatric surgery is currently the treatment of choice for those patients with severe obesity, but the procedure of choice is not clearly established. We describe weight loss and nutritional parameters in severely obesepatients after biliopancreatic diversion for 10 years of follow-up. METHODS:Patients were followed by the same multidisciplinary team, and data are shown for 10 years. Bariatric Analysis and Reporting Outcome System (BAROS) questionnaire, data regarding the evolution of obesity-related diseases, and nutritional parameters are reported. RESULTS: Two hundred ninety-nine patients underwent biliopancreatic diversion, 76.1 % women, initial BMI 50.1 kg/m(2) (7.2). Weight loss was maintained throughout 10 years with EWL% around 65 % and EBMIL% around 70 %. More than 80 % of the patients showed EWL higher than 50 %. Blood pressure, glucose metabolism, and lipid profile clearly improved after surgery. Mean nutritional parameters remained within the normal range during follow-up. Protein malnutrition affected less than 4 % and anemia up to 16 %. Fat-soluble vitamin levels decreased along the time, with vitamin D deficiency in 61.5 % of patients. No significant differences were found either in nutritional parameters or weight loss regarding gastrectomy or gastric preservation, or common limb length longer or shorter than 55 cm CONCLUSIONS: Biliopancreatic diversion is an effective surgical procedure in terms of weight loss, quality of life, and evolution of obesity-related diseases. Nutritional deficiencies are less frequent than feared for a malabsorptive procedure, but must be taken into account, especially for fat-soluble vitamins.
Entities:
Keywords:
Bariatric surgery; Biliopancreatic diversion; Long-term; Nutritional complications; Severe obesity
Authors: Pablo Vidal; José Manuel Ramón; Alberto Goday; Alejandra Parri; Xènia Crous; Lourdes Trillo; Manuel Pera; Luis Grande Journal: Obes Surg Date: 2014-02 Impact factor: 4.129
Authors: Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer Journal: Obesity (Silver Spring) Date: 2013-03 Impact factor: 5.002
Authors: C Vázquez; E Morejón; C Muñoz; Y López; J Balsa; M A Koning; A Maldonado; G García; R Peromingo; V Fresneda Journal: Nutr Hosp Date: 2003 Jul-Aug Impact factor: 1.057
Authors: Carlijn Kuin; Floor den Ouden; Hans Brandts; Laura Deden; Eric Hazebroek; Marcel van Borren; Hans de Boer Journal: Obes Surg Date: 2019-10 Impact factor: 4.129
Authors: Paula Volpe; Carlos Eduardo Domene; André Valente Santana; William Giglio Mira; Marco Aurélio Santo Journal: Arq Bras Cir Dig Date: 2022-06-17
Authors: Ana Carolina Junqueira Vasques; José Carlos Pareja; Maria da Saúde de Oliveira; Fernanda Satake Novaes; Marcelo Miranda Oliveira Lima; Élinton A Chaim; Francesca Piccinini; Chiara Dalla Man; Claudio Cobelli; Bruno Geloneze Journal: Obes Surg Date: 2016-11 Impact factor: 4.129
Authors: Paul E O'Brien; Annemarie Hindle; Leah Brennan; Stewart Skinner; Paul Burton; Andrew Smith; Gary Crosthwaite; Wendy Brown Journal: Obes Surg Date: 2019-01 Impact factor: 4.129